Professors Wassilios Meissner and Olivier Rascol of Toulouse University Hospital, who led the trial, said the findings constitute a significant step forward in the future management of the disease, adding that they "look forward to confirming these encouraging results in the future in order to translate such findings into clinical practice. According to neurology specialist Professor Tom Foltynie of University College London who was not involved in the study the new study is an important publication that replicates the findings of an earlier study in Parkinsons of a similar GLP-1 agonist, exenatide, which was published in The Lancet in 2017
Use protein shakes designed for GLP-1 patients if solid food intake is difficult during periods of strong appetite suppression
Individual participant change in PHQ-9, GAD-7 and EDE-Q scores are shown in Table 1
For the treatment and control of cobalt deficiency in sheep and cattle to maintain growth, reduce ill thrift and support energy and immunity
#HiringToday #SunPharma #PharmaNews #USTariffs #IndianPharma #GlobalTrade #PatentedDrugs Source: NewsBytes ( To view or add a comment, sign in Europes CDMO Market Set for Strong Growth
Does light affect the stability of reconstituted GHK-Cu
